CCR5 and Cancer
Published preclinical studies provide support for CCR5’s role in cancer and cancer metastasis. These studies demonstrate CCR5 inhibitors’ ability to effectively block breast and prostate cancer spread and to block human breast cancer metastasis. In preclinical studies CCR5 inhibitors blocked prostate cancer metastasis to the bones, the brain and other organs with high effectiveness. You can learn more about CCR5’s role in cancer viewing the videos and reading the articles below.